Neointima formation in a restenosis model is suppressed in midkine-deficient mice

被引:168
作者
Horiba, M
Kadomatsu, K
Nakamura, E
Muramatsu, H
Ikematsu, S
Sakuma, S
Hayashi, K
Yuzawa, Y
Matsuo, S
Kuzuya, M
Kaname, T
Hirai, M
Saito, H
Muramatsu, T
机构
[1] Nagoya Univ, Sch Med, Dept Biochem, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Nagoya Univ, Sch Med, Dept Internal Med 1, Nagoya, Aichi 4668550, Japan
[3] Meiji Cell Technol Ctr, Odawara, Kanagawa 2500862, Japan
[4] Nagoya Univ, Sch Med, Dept Int Med 3, Nagoya, Aichi 4668550, Japan
[5] Nagoya Univ, Sch Med, Dept Geriatr, Nagoya, Aichi 4668550, Japan
[6] Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Dept Dev Genet, Kumamoto 8620976, Japan
关键词
D O I
10.1172/JCI7208
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Neointima formation is a common feature of atherosclerosis and restenosis after balloon angioplasty. To find a new target to suppress neointima formation, we investigated the possible role of midkine (MK), a heparin-binding growth factor with neurotrophic and chemotactic activities, in neointima formation. MK expression increased during neointima formation caused by intraluminal balloon injury of the rat carotid artery. Neointima formation in a restenosis model was strongly suppressed in MK-deficient mice. Continuous administration of MK protein to MK-deficient mice restored neointima formation. Leukocyte recruitment to the vascular walls after injury was markedly decreased in MK-deficient mice. Soluble MK as well as that bound to the substratum induced migration of macrophages in vitro. These results indicate that MK plays a critical role in neointima formation at least in part owing to its ability to mediate leukocyte recruitment.
引用
收藏
页码:489 / 495
页数:7
相关论文
共 39 条
[1]  
BALCON R, 1992, CIRCULATION, V86, P100
[2]   PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine [J].
Banai, S ;
Wolf, Y ;
Golomb, G ;
Pearle, A ;
Waltenberger, J ;
Fishbein, I ;
Schneider, A ;
Gazit, A ;
Perez, L ;
Huber, R ;
Lazarovichi, G ;
Rabinovich, L ;
Levitzki, A ;
Gertz, SD .
CIRCULATION, 1998, 97 (19) :1960-1969
[3]   DIFFERENTIAL MODULATION OF VASCULAR CELL INTEGRIN AND EXTRACELLULAR-MATRIX EXPRESSION INVITRO BY TGF-BETA-1 CORRELATES WITH RECIPROCAL EFFECTS ON CELL-MIGRATION [J].
BASSON, CT ;
KOCHER, O ;
BASSON, MD ;
ASIS, A ;
MADRI, JA .
JOURNAL OF CELLULAR PHYSIOLOGY, 1992, 153 (01) :118-128
[4]   Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis [J].
Boring, L ;
Gosling, J ;
Cleary, M ;
Charo, IF .
NATURE, 1998, 394 (6696) :894-897
[5]   STIMULATION OF MIGRATION OF HUMAN AORTIC SMOOTH-MUSCLE CELLS BY VITRONECTIN - IMPLICATIONS FOR ATHEROSCLEROSIS [J].
BROWN, SL ;
LUNDGREN, CH ;
NORDT, T ;
FUJII, S .
CARDIOVASCULAR RESEARCH, 1994, 28 (12) :1815-1820
[6]  
CLOWES AW, 1983, LAB INVEST, V49, P208
[7]   Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin [J].
Czubayko, F ;
Schulte, AM ;
Berchem, GJ ;
Wellstein, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) :14753-14758
[8]   EFFECT OF 18-HOUR TO 24-HOUR HEPARIN ADMINISTRATION FOR PREVENTION OF RESTENOSIS AFTER UNCOMPLICATED CORONARY ANGIOPLASTY [J].
ELLIS, SG ;
ROUBIN, GS ;
WILENTZ, J ;
DOUGLAS, JS ;
KING, SB .
AMERICAN HEART JOURNAL, 1989, 117 (04) :777-782
[9]   LONG-TERM EFFECTS OF ANGIOPEPTIN TREATMENT IN CORONARY ANGIOPLASTY - REDUCTION OF CLINICAL EVENTS BUT NOT ANGIOGRAPHIC RESTENOSIS [J].
EMANUELSSON, H ;
BEATT, KJ ;
BAGGER, JP ;
BALCON, R ;
HEIKKILA, J ;
PIESSENS, J ;
SCHAEFFER, M ;
SURYAPRANATA, H ;
FOEGH, M .
CIRCULATION, 1995, 91 (06) :1689-1696
[10]   INHIBITION OF NEOINTIMAL SMOOTH-MUSCLE ACCUMULATION AFTER ANGIOPLASTY BY AN ANTIBODY TO PDGF [J].
FERNS, GAA ;
RAINES, EW ;
SPRUGEL, KH ;
MOTANI, AS ;
REIDY, MA ;
ROSS, R .
SCIENCE, 1991, 253 (5024) :1129-1132